Surgical Treatment of Hip Fractures Under Peripheral Regional Anesthesia
- Conditions
- Hip Fractures
- Interventions
- Registration Number
- NCT04005404
- Lead Sponsor
- Helios Research Center
- Brief Summary
The study investigates whether treatment of proximal femoral fractures is possible using a peripheral regional anesthesia technique.
- Detailed Description
The study investigates whether treatment of proximal femoral fractures is possible using a peripheral regional anesthesia technique.
After positioning on the non-fractured side, a double injection technique is used (dual guidance concept: nerve stimulation and sonography).
The injections are performed parasacrally (blockade of the sacral plexus under the piriformis muscle) and lumbar paravertebrally (psoas compartment block and transmuscular quadratus lumborum block). Per block 20 ml ropivacaine 0.375% is administered (total dose: 225mg ropivacaine).
The study examines the success rate (rate of successfully performed nerve blockade; need for supplemental medication: sufentanil and/or propofol; conversion rate to general anesthesia), circulatory stability (need for application of ephedrine or norepinephrine) and side effects.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- proximal femoral fracture
- older then 18 years
- written informed consent
- local or systematic inflammation
- allergy to ropivacaine
- participate in other studies
- body mass index over 35
- periprosthetic fractures
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description neck femur fractures Ropivacaine (sciatic nerve block) geriatric patients with neck of femur fracture who have consented to the study intervention neck femur fractures Ropivacaine (lumbar plexus block L2-L4) geriatric patients with neck of femur fracture who have consented to the study intervention intertrochanteric femoral fractures Ropivacaine (sciatic nerve block) geriatric patients with intertrochanteric femoral fracture who have consented to the study intervention intertrochanteric femoral fractures Ropivacaine (lumbar plexus block L2-L4) geriatric patients with intertrochanteric femoral fracture who have consented to the study intervention subtrochanteric femoral fractures Ropivacaine (sciatic nerve block) geriatric patients with subtrochanteric femoral fracture who have consented to the study intervention subtrochanteric femoral fractures Ropivacaine (lumbar plexus block L2-L4) geriatric patients with subtrochanteric femoral fracture who have consented to the study intervention intertrochanteric femoral fractures Ropivacaine (lumbar plexus block Th12-L1) geriatric patients with intertrochanteric femoral fracture who have consented to the study intervention neck femur fractures Ropivacaine (lumbar plexus block Th12-L1) geriatric patients with neck of femur fracture who have consented to the study intervention subtrochanteric femoral fractures Ropivacaine (lumbar plexus block Th12-L1) geriatric patients with subtrochanteric femoral fracture who have consented to the study intervention
- Primary Outcome Measures
Name Time Method Success Rate (Conversion to General Anesthesia) during surgery number of participants with need for conversion to general anesthesia
Success Rate (Supplemental Medication) during surgery number of participants with need for supplemental analgesic medication (sufentanil)
- Secondary Outcome Measures
Name Time Method Circulation Stability during surgery number of participants with need for application of ephedrine and/or norepinephrine
Trial Locations
- Locations (1)
Helios Medical Center Schwerin, Department of Anesthesiology
🇩🇪Schwerin, Mecklenburg-Vorpommern, Germany